North America Pharmaceutical Excipients Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Type (Bioresorbable Polymers, and Lipids and Liposome-Based Formulation; Oleochemicals; Sugars; Cellulose; Starches; Petrochemicals; Plant Proteins and Polyols and Cyclodextrins; Inorganic Chemicals; and Others), Clinical Indication (Cancer, Metabolic, Infectious Diseases, Dental, Ophthalmic, Gene Therapies, and Others), Functionality (Coloring Agent and Coating Agent, Sweetener and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled-Release, Antioxidant and Oil, Tablet Filler and Diluents, Binders and Compression Aids and Granulating Agents, and Others), Application (Parenteral, Oral Formulations and Tablets, Capsules, Liquid and Injectables, Physicochemical Excipient-Container Interactions in Prefilled Syringes, Nutraceuticals and OTC, Topical, and Others), and End User (Biopharma Industries, Pharma Industries, Animal Health, and Others)   

No. of Pages: 256
Report Code: TIPRE00022815
Category: Chemicals and Materials
North America Pharmaceutical Excipients Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Pharmaceutical Excipients Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Pharmaceutical Excipients Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Pharmaceutical Excipients Market Regional Analysis

6.2 North America Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)
6.3 North America Pharmaceutical Excipients Market Forecast Analysis

7. North America Pharmaceutical Excipients Market Analysis – by Type

7.1 Bioresorbable Polymers
  • 7.1.1 Overview
  • 7.1.2 Bioresorbable Polymers: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Lipids and Liposome-Based Formulation
  • 7.2.1 Overview
  • 7.2.2 Lipids and Liposome-Based Formulation: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Oleochemicals
  • 7.3.1 Overview
  • 7.3.2 Oleochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Sugars
  • 7.4.1 Overview
  • 7.4.2 Sugars: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.5 Cellulose
  • 7.5.1 Overview
  • 7.5.2 Cellulose: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.6 Starches
  • 7.6.1 Overview
  • 7.6.2 Starches: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.7 Petrochemicals
  • 7.7.1 Overview
  • 7.7.2 Petrochemicals: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.8 Plant Proteins and Polyols and Cyclodextrins
  • 7.8.1 Overview
  • 7.8.2 Plant Proteins and Polyols and Cyclodextrins: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.9 Inorganic Chemicals
  • 7.9.1 Overview
  • 7.9.2 Inorganic Chemicals : North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.10
  • 7.10.1 Overview
  • 7.10.2 : North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Pharmaceutical Excipients Market Analysis – by Clinical Indication

8.1 Cancer
  • 8.1.1 Overview
  • 8.1.2 Cancer: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Metabolic
  • 8.2.1 Overview
  • 8.2.2 Metabolic: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Infectious Diseases
  • 8.3.1 Overview
  • 8.3.2 Infectious Diseases: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Dental
  • 8.4.1 Overview
  • 8.4.2 Dental: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Ophthalmic
  • 8.5.1 Overview
  • 8.5.2 Ophthalmic: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.6 Gene Therapies
  • 8.6.1 Overview
  • 8.6.2 Gene Therapies: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Pharmaceutical Excipients Market Analysis – by Functionality

9.1 Coloring Agent and Coating Agent
  • 9.1.1 Overview
  • 9.1.2 Coloring Agent and Coating Agent: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Sweetener and Flavoring Agents
  • 9.2.1 Overview
  • 9.2.2 Sweetener and Flavoring Agents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Suspending and Viscosity Agents
  • 9.3.1 Overview
  • 9.3.2 Suspending and Viscosity Agents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Preservative and Controlled-Release
  • 9.4.1 Overview
  • 9.4.2 Preservative and Controlled-Release: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.5 Antioxidant and Oil
  • 9.5.1 Overview
  • 9.5.2 Antioxidant and Oil: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.6 Tablet Filler and Diluents
  • 9.6.1 Overview
  • 9.6.2 Tablet Filler and Diluents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.7 Binders and Compression Aids and Granulating Agents
  • 9.7.1 Overview
  • 9.7.2 Binders and Compression Aids and Granulating Agents: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Pharmaceutical Excipients Market Analysis – by Application

10.1 Parenteral
  • 10.1.1 Overview
  • 10.1.2 Parenteral: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Oral Formulations and Tablets
  • 10.2.1 Overview
  • 10.2.2 Oral Formulations and Tablets: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.3 Capsules
  • 10.3.1 Overview
  • 10.3.2 Capsules: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.4 Liquid and Injectables
  • 10.4.1 Overview
  • 10.4.2 Liquid and Injectables: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.5 Physicochemical Excipient-Container Interactions in Prefilled Syringes
  • 10.5.1 Overview
  • 10.5.2 Physicochemical Excipient-Container Interactions in Prefilled Syringes: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.6 Nutraceuticals and OTC
  • 10.6.1 Overview
  • 10.6.2 Nutraceuticals and OTC: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.7 Topical
  • 10.7.1 Overview
  • 10.7.2 Topical: North America Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. North America Pharmaceutical Excipients Market – North America Analysis

11.1 Overview

11.2 North America
  • 11.2.1 North America Pharmaceutical Excipients Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 11.2.1.1 North America Pharmaceutical Excipients Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 US: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 US: North America Pharmaceutical Excipients Market Breakdown, by Type
    • 11.2.1.1.2 US: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
    • 11.2.1.1.3 US: North America Pharmaceutical Excipients Market Breakdown, by Functionality
    • 11.2.1.1.4 US: North America Pharmaceutical Excipients Market Breakdown, by Application
  • 11.2.1.2 Canada: North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Canada: North America Pharmaceutical Excipients Market Breakdown, by Type
    • 11.2.1.2.2 Canada: North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
    • 11.2.1.2.3 Canada: North America Pharmaceutical Excipients Market Breakdown, by Functionality
    • 11.2.1.2.4 Canada: North America Pharmaceutical Excipients Market Breakdown, by Application
  • 11.2.1.3 Mexico : North America Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Type
    • 11.2.1.3.2 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Clinical Indication
    • 11.2.1.3.3 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Functionality
    • 11.2.1.3.4 Mexico : North America Pharmaceutical Excipients Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Archer-Daniels-Midland Co
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 AshLand Inc
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Avantor Inc
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 BASF SE
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Evonik Industries AG
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 JRS PHARMA GmbH & Co. KG
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 MEGGLE GmbH & Co KG
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Roquette Freres SA
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 The Dow Chemical Co
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments
14.10 The Lubrizol Corp
  • 14.10.1 Key Facts
  • 14.10.2 Business Description
  • 14.10.3 Products and Services
  • 14.10.4 Financial Overview
  • 14.10.5 SWOT Analysis
  • 14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - North America Pharmaceutical Excipients Market

  • Archer-Daniels-Midland Co
  • AshLand Inc
  • Avantor Inc
  • BASF SE
  • Evonik Industries AG
  • JRS PHARMA GmbH & Co. KG
  • MEGGLE GmbH & Co KG
  • Roquette Freres SA
  • The Dow Chemical Co
  • The Lubrizol Corp
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)